4 articles
The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for…
The post analyses patent law updates relating to COVID-19, including India’s push for TRIPS flexibilities and scrutiny of Gilead’s Remdesvir patent. It also covers the EPO’s stance on…
BananaIP is offering free patent and design filings in India for eligible COVID-19 related inventions if applicants adopt the Open COVID Pledge. This initiative aims to encourage innovation…
The post explores the preference for collaborative and open innovation during the COVID-19 crisis, detailing the decline in IP filings and the shift away from IP exclusivity. It…